Anti-Malarial Drugs Market is anticipated to flourish at a CAGR of 3.8% over the forecast period 2019-2024

KD Market Insights has published a new report on  Anti-Malarial Drugs Market analysis and forecast 2014-2024. The report comprises of Anti-Malarial Drugs Market size, Y-o-Y growth analysis, and market dynamics, including growth drivers, restraining factors, opportunities, and trends which are spearheading current nature and future status of the market.

The anti-malarial drugs market is anticipated to flourish at a CAGR of 3.8% over the forecast period i.e. 2019-2024. Further, the market for anti-malarial drugs was valued at USD XXX.X Million in 2018.

Request for Sample @ https://www.kdmarketinsights.com/sample/5430

Growth Drivers – Anti-Malarial Drugs Market

Increasing Cases of Malaria
According to World Health Organization, there were 219 million cases of malaria across the world in 2017. This represented an increase of 2 million as compared to 2016. Moreover, malaria resulted in death of 435 thousand people and children in 2016. Further, government initiatives and healthcare organizations attempt to reduce case of malaria is expected to positively impact the growth of global anti-malarial drugs market.

Increasing Anti-Malaria Products Discovery Projects
Continuous growth in research and development activities is anticipated to positively impel the growth of global anti-malarial drugs market. Apart from this, favourable support from government and funding from other organization is resulting in increased research and development activities. This factor is envisioned to bolster the growth of global anti-malarial drugs market.

Barriers – Anti-Malarial Drugs Market

Associated Side Effects with Anti-malarial Drugs
Factors such as possible side effects of malaria drugs including insomnia, dizziness, anxiety and others are anticipated to hamper the growth of global anti-malarial drugs market.

Segmentation Analysis
The anti-malarial drugs market by drug type is segmented into quinine, chloroquine, pyrimethamine, amodiaquine, proguanil, mefloquine, sulfonamide, artemisinin & derivatives, atovaquone, primaquine, halofantrine, doxycycline, and clindamycin. The market for quinine is anticipated to witness significant growth during the forecast period.
Further, global anti-malarial drugs market is also segmented by distribution channel into hospital pharmacy, retail pharmacy, e-commerce, and others. Retail pharmacy segment captured significant market share during the forecast period. Further, e-commerce segment is anticipated to witness highest growth in the upcoming years.

Geographical Analysis
Geographically, the report offers analysis of North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In anti-malarial drugs market, Middle East & Africa captured the largest percentage of market in global anti-malarial drugs market. With a market share of approximately 47.3% in 2018, MEA market contributed majorly in global anti-malarial drugs market. According to WHO, Sub-Saharan Africa accounted for 90% of malaria deaths worldwide in 2013. In addition, DRC and Nigeria accounted for more than 40% deaths from malaria in the region. Asia Pacific anti-malarial drugs market is anticipated to witness robust growth during the forecast period. South East Asia has highest number of malaria cases after African region. Further, government of South East Asian countries and various healthcare organizations are making significant investment to reduce cases and deaths from malaria. This factor is envisioned to bolster the growth of Asia anti-malarial drugs market.

Competitive Landscape
The report profiles various major market players such as;

- GlaxoSmithKline Plc
- Ranbaxy Laboratories
- Zydus Cadila
- Alvizia Health Care
- Bayer AG
- Pfizer, Inc.
- Ipca Laboratories Ltd
- Merck KGaA
- F. Hoffmann-La Roche AG
- Novartis AG
- Other Major & Niche Players

Competitive landscape analysis provides detailed strategic analysis of the company’s business and performance such as financial information, revenue breakup by segment and by geography, SWOT Analysis, key facts, company overview, business strategy, key product offerings, marketing and distribution strategies, new product development, recent news (acquisition, expansion, technology development, research & development and other market activities).
The study also provides company’s positioning and market share in anti-malarial drugs market.

Browse Full Report With TOC@ https://www.kdmarketinsights.com/product/anti-malarial-drugs-market

Table of Content

1. Preface
1.1. Research Methodology
1.2. Geographic Scope
1.3. Years Considered

2. Executive Summary

3. Market Overview
3.1. Anti-Malarial Drugs Overview
3.2. Market Definition & Key Market Segments
3.3. Industry Development
3.4. Global Market Maturity
3.4.1. North America
3.4.2. Europe
3.4.3. Asia Pacific
3.4.4. Latin America
3.4.5. Middle East & Africa
3.5. Porter’s Five Force Analysis
3.6. Industry Value Chain Analysis
3.7. Macro-Economic Trends

4. Competitive Landscape
4.1. Global Anti-Malarial Drugs Market 2018
4.2. Global h Anti-Malarial Drugs Market Value Share, By Company 2018

5. Growth Drivers & Barriers in Global Anti-Malarial Drugs Market
5.1. North America
5.2. Europe
5.3. Asia Pacific
5.4. Rest of World

6. Trends in Global Anti-Malarial Drugs Market
6.1. North America
6.2. Europe
6.3. Asia Pacific
6.4. Rest of World

7. Global Anti-Malarial Drugs Market
7.1. Introduction
7.2. Historical Market Value (USD Million) 2014-2017 Market Value Forecast (USD Million) & Y-o-Y Growth Analysis, 2018-2024

8. Global Anti-Malarial Drugs Market Segmentation Analysis, By Drug Type
8.1. Introduction
8.2. Strategic Insights
8.2.1. BPS Analysis, By Drug Type
8.2.2. Market Attractiveness, By Drug Type
8.3. Quinine
8.3.1. Historical Market Value (USD Million) 2014-2017 Market Value Forecast (USD Million) & Y-o-Y Growth Analysis, 2018-2024
8.4. Chloroquine
8.4.1. Historical Market Value (USD Million) 2014-2017 Market Value Forecast (USD Million) & Y-o-Y Growth Analysis, 2018-2024
8.5. Pyrimethamine
8.5.1. Historical Market Value (USD Million) 2014-2017 Market Value Forecast (USD Million) & Y-o-Y Growth Analysis, 2018-2024
8.6. Amodiaquine
8.6.1. Historical Market Value (USD Million) 2014-2017 Market Value Forecast (USD Million) & Y-o-Y Growth Analysis, 2018-2024
8.7. Proguanil
8.7.1. Historical Market Value (USD Million) 2014-2017 Market Value Forecast (USD Million) & Y-o-Y Growth Analysis, 2018-2024
8.8. Mefloquine
8.8.1. Historical Market Value (USD Million) 2014-2017 Market Value Forecast (USD Million) & Y-o-Y Growth Analysis, 2018-2024
8.9. Sulfonamide
8.9.1. Historical Market Value (USD Million) 2014-2017 Market Value Forecast (USD Million) & Y-o-Y Growth Analysis, 2018-2024
8.10. Artemisinin & derivatives
8.10.1. Historical Market Value (USD Million) 2014-2017 Market Value Forecast (USD Million) & Y-o-Y Growth Analysis, 2018-2024
8.11. Atovaquone
8.11.1. Historical Market Value (USD Million) 2014-2017 Market Value Forecast (USD Million) & Y-o-Y Growth Analysis, 2018-2024
8.12. Primaquine
8.12.1. Historical Market Value (USD Million) 2014-2017 Market Value Forecast (USD Million) & Y-o-Y Growth Analysis, 2018-2024
8.13. Halofantrine
8.13.1. Historical Market Value (USD Million) 2014-2017 Market Value Forecast (USD Million) & Y-o-Y Growth Analysis, 2018-2024
8.14. Doxycycline
8.14.1. Historical Market Value (USD Million) 2014-2017 Market Value Forecast (USD Million) & Y-o-Y Growth Analysis, 2018-2024
8.15. Clindamycin
8.15.1. Historical Market Value (USD Million) 2014-2017 Market Value Forecast (USD Million) & Y-o-Y Growth Analysis, 2018-2024

Continue…

Check for Discount @ https://www.kdmarketinsights.com/discount/5430

About KD Market Insights

KD Market Insights offers a comprehensive database of syndicated research studies, customized reports, and consulting services. These reports are created to help in making smart, instant and crucial decisions based on extensive and in-depth quantitative information, supported by extensive analysis and industry insights.

Our dedicated in-house team ensures the reports satisfy the requirement of the client. We aim at providing value service to our clients. Our reports are backed by extensive industry coverage and is made sure to give importance to the specific needs of our clients. The main idea is to enable our clients to make an informed decision, by keeping them and ourselves up to date with the latest trends in the market.

Contact Us

KD Market Insights

150 State Street, Albany,

New York, USA 12207

+1 (518) 300-1215

Email: sales@kdmarketinsights.com

Website: www.kdmarketinsights.com

Read More News: http://kdmarketinsights.blogspot.com/

https://marketreserachtab.blogspot.com/